| Literature DB >> 26226952 |
Benjamin Frank1, Ana Marcu2, Antonio Luis de Oliveira Almeida Petersen3,4, Heike Weber5, Christian Stigloher6, Jeremy C Mottram7, Claus Juergen Scholz8, Uta Schurigt9.
Abstract
BACKGROUND: Autophagy participates in innate immunity by eliminating intracellular pathogens. Consequently, numerous microorganisms have developed strategies to impair the autophagic machinery in phagocytes. In the current study, interactions between Leishmania major (L. m.) and the autophagic machinery of bone marrow-derived macrophages (BMDM) were analyzed.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26226952 PMCID: PMC4521392 DOI: 10.1186/s13071-015-0974-3
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Ultrastructural investigation of autophagy induction in L. m.-infected BMDM with TEM. Methods: BMDM from BALB/c mice were infected with L. m. promastigotes for (e, f, i, j, m, n) 1 h and (g, h, k, l, o, p) 24 h. a–d Uninfected BMDM were incubated for the same amount of time in RPMI medium. All BMDM were subjected to TEM analyses. Results: Autophagic phenotypes characterized by (e–h) a strong vacuolization, (i, k) presence of MLS and (j, l) autophagosomes detected in L. m.-infected BMDM 1 h p.i. and 24 h p.i. compared to uninfected control BMDM. Details in images (i–p) were magnified from images (e–h) from sections of L. m.-infected BMDM (red squares = MLS in i and k, red circles = autophagosomes in j and l, black squares = intracellular parasites in m–p). K = kinetoplast, kDNA = kinetoplastid DNA, L = lysosome-like vacuole, M = mitochondrion, N = nucleus of macrophage, NP = nucleus of parasite, P = parasite
Fig. 2Autophagy assessment in L. m.-infected BMDM with TEM and LC3B western blot analyses. Methods: (a–c) BMDM from BALB/c mice were infected with L. m. promastigotes for 1 h or 24 h. Uninfected control BMDM were incubated for the same amount of time in RPMI medium. a All BMDM were subjected to TEM analyses. 50 BMDM from each sample were semiquantitatively analyzed for the grade of vacuolization (0 – 3) and the presence of MLS (+1), which resulted in a total autophagy score (maximum = 4). The total autophagy score and frequency of MLS were calculated. b, c Additionally, proteins were isolated from L. m.-infected and uninfected BMDM as well as from HBSS-starved BMDM to monitor autophagy with LC3B western blotting. Cell cultures were partially treated with Baf A1 to monitor autophagic flux. Western blots with proteins from 3 independent experiments were analyzed densitometrically. ACTB served as the internal loading control. Results: (a) The total autophagy score and the frequency of MLS were significantly increased in L. m.-infected BMDM 1 and 24 h p.i. compared to uninfected controls. There were no significant differences between L. m.-infected BMDM 1 and 24 h p.i.. b LC3B-II levels in samples from L. m.-infected BMDM 1 and 24 h p.i. were increased compared to uninfected controls. An accumulation of LC3B-II was visible in all Baf A1-treated samples (+ Baf A1) compared to controls (− Baf A1), which indicates an autophagic flux. c Results of densitometric analyses showed that LC3B-II levels and the LC3B-II/LC3B-I ratios were significantly increased in L. m.-infected BMDM 1 and 24 h p.i. compared to uninfected controls. Furthermore, the LC3B-II/LC3B-I ratio of L. m.-infected BMDM 24 h p.i. compared to 1 h p.i. was significantly increased. Baf A1 = Bafilomycin A1, L. m.-inf. = L. m.-infected, n.s. = not significant, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001
Fig. 9Time course experiments of BNIP3 and CTSE western blot analyses with protein extracts from L. m.-infected BMDM, total autophagy scores, determination of the nucleus-kinetoplast distances, and infection rates. Methods: (a–e) BMDM from BALB/c mice were infected with L. m. promastigotes up to 48 h p.i.. Uninfected controls were incubated for the same amount of time in RPMI medium. a, b Proteins were harvested and subjected to western blot analysis. Protein expressions of L. m.-infected BMDM were analyzed densitometrically. ACTB served as the internal loading control. c L. m.-infected and uninfected BMDM were subjected to TEM analyses. 50 BMDM of each sample were analyzed semiquantitatively for the grade of vacuolization (0 – 3) and the presence of MLS (+1) resulting in the total autophagy score (maximum = 4). d, e L. m.-infected BMDM were stained with a Diff-Quik kit to determine (d) the distances between the parasite nuclei and the kinetoplasts and (e) the infection rates for each investigated time point. Results: (a) BNIP3 and CTSE overexpression in L. m.-infected BMDM increased over time up to 24 h p.i. compared to uninfected controls. b This overexpression was confirmed densitometrically for BNIP3 (dark gray columns) and CTSE (light gray columns). c The total autophagy score was significantly increased in L. m.-infected BMDM (red columns) in all investigated samples compared to uninfected controls (blue columns). In L. m.-infected BMDM at 2 to 10 h p.i., a significant decline in the total autophagy score was detectable compared to L. m.-infected BMDM at 1 h p.i.. This decline might has been caused by a partial autophagy inhibition. The total autophagy score significantly rose in L. m.-infected BMDM at 24 h p.i. compared to 10 h p.i.. The total autophagy score declined in uninfected controls from 0.5 h until 24 h. d The distance between nucleus and kinteoplast shortened over time, which confirmed the differentiation of promastigotes into amastigotes (black dots). e The infection rates increased over time up to 24 h p.i. (green columns). Between 1 and 24 h p.i., there were no significant changes in the infection rates, which indicated an inhibition of autophagic activity. Finally, the infection rates declined from 24 h p.i. until 48 h p.i., which suggested that parasites were autophagically digested. L. m.-inf. = L. m.-infected, n.s. = not significant, p.i. = post infection, (*) p ≤ 0.1, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001
Fig. 3Ultrastructural investigation of autophagy induction in L. m.-infected RAW 264.7 macrophages with TEM. Methods: RAW 264.7 macrophages were infected with L. m. promastigotes for (d, g, j) 0.5 h and (e, f, h, i, k, l) 24 h. a–c Uninfected BMDM were incubated for the same amount of time in RPMI medium. All macrophages were subjected to TEM analysis. Results: Autophagic phenotypes characterized by (d–f) a strong vacuolization, (g, h) the presence of MLS, (l) autophagosomes, and (i) phagophores were observed in L. m.-infected RAW 264.7 macrophages 0.5 h p.i. and 24 h p.i. compared to uninfected controls. Details in images (g–l) were magnified from images (d–f) from a total section of L. m.-infected BMDM (red squares = MLS in g and h, red circle = phagophore in i, black circle = autophagosome in l, black squares = intracellular parasites in j and k). N = nucleus of macrophage, NP = nucleus of parasite, P = parasite
Fig. 4ATG5 and UB western blot analyses with protein extracts from L. m.-infected and HBSS-starved BMDM as well as determination of the infection rates of L. m.-infected BMDM after ATG5 and UB downregulation by RNA interference. Methods: (a, b) BMDM from BALB/c mice were infected with L. m. promastigotes for 1 and 24 h. Uninfected control BMDM were incubated for the same time in RPMI medium or starved for 1 h in HBSS. The proteins were harvested and subjected to western blot analysis with specific antibodies against ATG5 and UB. Western blots with proteins from 3 independent experiments were analyzed densitometrically. ACTB served as the internal loading control. c Additionally, BMDM were transfected with specific siRNAs 4 h prior to infection to downregulate the expression of ATG5 and UB. The cells were finally infected with L. m. promastigotes. L. m.-infected control BMDM were transfected with negative control siRNA. The infection rates were determined 48 h p.i.. Diagram shows the result of 2 independent experiments. Results: (a) ATG5 and UB levels in samples from L. m.-infected BMDM 24 h p.i. were increased compared to uninfected control BMDM. b Results of the densitometric analyses confirmed that ATG5 and UB were significantly increased in L. m.-infected BMDM 24 h p.i. compared to uninfected control BMDM. No upregulation was detected in L. m.-infected BMDM 1 h p.i. compared to the respective controls. c A significant increase in the infection rate was found in L. m.-infected BMDM after downregulation of the protein expression of ATG5 or UB compared to L. m.-infected BMDM transfected with negative control siRNA. L. m.-inf. = L. m.-infected, neg. control = negative control, n.s. = not significant, * p ≤ 0.05, *** p ≤ 0.001
Fig. 5Ultrastructural investigation of parasite-associated localization of MLS with TEM. Methods: BMDM from BALB/c mice were infected with L. m. promastigotes for 24 h and subjected to TEM analyses. Results: MLS were frequently observed (a) in the cytoplasm of BMDM closely associated with intracellular amastigotes, and (c) localized in the cytoplasm of parasites. e Additionally, digested amastigotes with a defective cell membrane and remains of intracellular MLS were found in L. m.-infected BMDM 24 h p.i.. (b, d, f) Schematic illustrations of images (a, c, and e), respectively
Fig. 6MTOR and RPS6 transcriptomic and western blot analyses with RNAs and protein extracts from L. m.-infected and HBSS-starved BMDM, and determination of infection rates of L. m.-infected BMDM after MTOR downregulation by RNA interference. Methods: (a, b) BMDM from BALB/c mice were infected with L. m. promastigotes for 1 or 24 h. Uninfected control BMDM were incubated for the same amount of time in RPMI medium or starved for 1 h in HBSS. Proteins were harvested and subjected to western blot analyses with specific antibodies against MTOR, p-MTOR, RPS6, and p-RPS6. Western blots with proteins from 3 independent experiments were analyzed densitometrically. ACTB served as the internal loading control. Total RNA was harvested from L. m.-infected BMDM and uninfected control BMDM. The Affymetrix® chips were hybridized with RNA samples from 2 independent experiments were analyzed densitometrically. c Additionally, BMDM were transfected with specific siRNA 4 h prior to infection to downregulate the expression of MTOR, and the cells were finally infected with L. m. promastigotes. L. m.-infected controls were transfected with negative control siRNA. The infection rates were determined 48 h p.i. in 2 independent experiments. Results: (a) A significant hyperphosphorylation was observed for MTOR and RPS6 in samples from L. m.-infected BMDM 1 h p.i. compared to uninfected control BMDM. b Results of densitometric analyses of western blot experiments and Affymetrix® chip analyses showed that MTOR and RPS6 expressions were not regulated at the mRNA or the protein level. However, MTOR and RPS6 were significantly hyperphosphorylated in L. m.-infected BMDM 1 h p.i.. c A significant decrease in the infection rate was detected in L. m.-infected BMDM after downregulation of the protein expression of MTOR compared to L. m.-infected BMDM transfected with negative control siRNA. L. m.-inf. = L. m.-infected, neg. control = negative control, n.s. = not significant, RFU = relative fluorescence units, * p ≤ 0.05, ** p ≤ 0.01
Fig. 7Global analysis of differentially expressed mRNAs in L. m.-infected BMDM and MIF western blot analyses with protein extracts from L. m.-infected and HBSS-starved BMDM. Methods: (a–e) BMDM from BALB/c mice were infected with L. m. promastigotes for 1 or 24 h. Uninfected control BMDM were incubated for the same amount of time in RPMI medium. Total RNA from 2 independent experiments was harvested from L. m.-infected BMDM or uninfected controls and hybridized with Affymetrix® chips. The BMDM were additionally incubated for 1 h in HBSS. Proteins were harvested and subjected to western blot analyses with specific antibodies against MIF. The western blots from 3 independent experiments were analyzed densitometrically. ACTB served as the internal loading control. Results: (a) Differentially expressed genes were detected in L. m.-infected BMDM 1 and 24 h p.i.. The results were presented in MA plots. Large dots represent probe sets, which had significant differential expression (FDR < 0.05). Dot colors correspond to the direction of gene expression changes (red dots = significant upregulation; blue dots = significant downregulation). b At 1 h p.i., 61 probe sets and 878 probe sets at 24 h p.i. had significant differential expression in L. m.-infected BMDM. 25 probe sets had significant differential expression at both time points. The results were presented in a Venn diagram. c MIF was overexpressed in L. m.-infected BMDM 24 h p.i. compared to uninfected control BMDM. d Results of densitometric analyses of the western blots and of the corresponding Affymetrix® chip analysis confirmed MIF overexpression at the mRNA and the protein level in L. m.-infected BMDM 24 h p.i. compared to uninfected control BMDM. e 28 autophagy-related genes in L. m.-infected BMDM 24 h p.i. were LISA members. The edges represent known protein-protein interactions determined in the AIN. The colors correspond to the direction of the gene expression changes (red = significant upregulation; blue = significant downregulation). L. m.-inf. = L. m.-infected, n.s. = not significant, p.i. = post infection, RFU = relative fluorescence units, * = genes of glycolysis, *** p ≤ 0.001
Selected differentially expressed host cell genes in L. m.-infected BMDM
|
| |||
| Gene name (probe set ID) | Symbol | logFC | |
| Additional autophagy-related genes | |||
| BCL2/adenovirus E1B interacting protein 3 (1422470_at) |
| 0.417 | |
|
| |||
| Gene name (probe set ID) | Symbol | logFC | |
| LISA | |||
| ATP-binding cassette, sub-family E (OABP), member 1 (1416014_at) |
| 0.392 | |
| Acyl-CoA synthetase long-chain family member 4 (1418911_s_at) |
| 0.347 | |
| AHA1, activator of heat shock protein ATPase homolog 1 (yeast) (1424147_at) |
| 0.422 | |
| Aldolase A, fructose-bisphosphate (1433604_x_at) |
| 0.496 | |
| Adaptor protein complex AP-2, alpha 2 subunit (1432007_s_at) |
| −0.536 | |
| DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 (1447789_x_at) |
| 0.598 | |
| Eukaryotic translation initiation factor 2-alpha kinase 2 (1440866_at) |
| 0.533 | |
| Enolase 2, gamma neuronal (1418829_a_at) |
| 0.673 | |
| FUN14 domain containing 1 (1453369_a_at) |
| −0.357 | |
| Fusion, derived from t(12;16) malignant liposarcoma (human) (1451285_at) |
| 0.397 | |
| Glyceraldehyde-3-phosphate dehydrogenase (1447999_x_at) |
| 0.506 | |
| Helicase, lymphoid specific (1417541_at) |
| 0.505 | |
| Heat shock protein 90, alpha (cytosolic), class A member 1 (1426645_at) |
| 0.543 | |
| Potassium channel tetramerisation domain containing 12 (1434881_s_at) |
| −0.419 | |
| Lactate dehydrogenase A (1419737_a_at) |
| 0.558 | |
| Microtubule-associated protein 1 light chain 3 beta (1415929_at) |
| −0.445 | |
| Minichromosome maintenance deficient 3 ( |
| 0.365 | |
| Macrophage migration inhibitory factor (1416335_at) |
| 0.731 | |
| Asparaginyl-tRNA synthetase (1428666_at) |
| −0.384 | |
| N-myc downstream regulated gene 1 (1420760_s_at) |
| 0.545 | |
| Nuclear factor of activated T cells 5 (1438999_a_at) |
| −0.401 | |
| Phosphoglycerate kinase 1 (1417864_at) |
| 0.730 | |
| Pyruvate kinase, muscle (1417308_at) |
| 0.471 | |
| Protein kinase, AMP-activated, gamma 2 non-catalytic subunit (1423831_at) |
| −0.498 | |
| Sorbitol dehydrogenase (1438183_x_at) |
| −0.385 | |
| Tripartite motif-containing 21 (1418077_at) |
| 0.400 | |
| Thioredoxin reductase 1 (1421529_a_at) |
| 0.448 | |
| Zinc finger, CCHC domain containing 11 (1437395_at) |
| −0.477 | |
| Additional autophagy-related genes | |||
| BCL2/adenovirus E1B interacting protein 3 (1422470_at) |
| 0.765 | |
| Cathepsin E (1418989_at) |
| −0.852 | |
| DNA-damage regulated autophagy modulator 1 (1424524_at) |
| 0.445 | |
| Optineurin (1435679_at) |
| 0.355 | |
| Syntaxin 5A (1449679_s_at) |
| −0.429 | |
| Vacuolar protein sorting 41 (yeast) (1437901_a_at) |
| −0.423 | |
| Glycolysis (GO accession: GO:0006096) | |||
| Fructose-bisphosphate aldolase A (1433604_x_at) |
| 0.496 | |
| Fructose-bisphosphate aldolase C (1451461_a_at) |
| 0.636 | |
| Enolase 2 (1418829_a_at) |
| 0.673 | |
| Glyceraldehyde-3-phosphate dehydrogenase (1447999_x_at) |
| 0.506 | |
| Lactate dehydrogenase A (1419737_a_at) |
| 0.558 | |
| Phosphoglycerate kinase 1 (1417864_at) |
| 0.730 | |
| Phosphoglycerate mutase 1 (1426554_a_at) |
| 0.546 | |
| Pyruvate kinase, muscle (1417308_at) |
| 0.471 | |
| Protein kinase, AMP-activated, gamma 2 non-catalytic subunit (1423831_at) |
| −0.498 | |
| Triosephosphate isomerase 1 (1415918_a_at) |
| 0.670 | |
| Immune response (GO accession: GO:0006955) | |||
| BCL2/adenovirus E1B interacting protein 3 (1422470_at) |
| 0.765 | |
| Complement component 3 (1423954_at) |
| 1.294 | |
| Cell adhesion molecule 1 (1431611_a_at) |
| −0.424 | |
| Chemokine (C-C motif) ligand 12 (1419282_at) |
| 0.515 | |
| Chemokine (C-C motif) ligand 2 (1420380_at) |
| 0.738 | |
| Chemokine (C-C motif) ligand 24 (1450488_at) |
| −0.485 | |
| Chemokine (C-C motif) ligand 3 (1419561_at) |
| 0.643 | |
| Chemokine (C-C motif) ligand 4 (1421578_at) |
| 0.710 | |
| Chemokine (C-C motif) ligand 5 (1418126_at) |
| 2.250 | |
| Chemokine (C-C motif) ligand 7 (1421228_at) |
| 0.523 | |
| CD180 antigen (1421547_at) |
| 0.382 | |
| CD28 antigen (1437025_at) |
| −0.482 | |
| CD300A antigen (1445292_at) |
| −0.441 | |
| Complement component factor h (1423153_x_at) |
| −0.783 | |
| C-type lectin domain family 5, member a (1421366_at) |
| 0.804 | |
| Chemokine (C-X3-C) receptor 1 (1450020_at) |
| −0.379 | |
| Chemokine (C-X-C motif) ligand 1 (1419209_at) |
| 0.808 | |
| Chemokine (C-X-C motif) ligand 10 (1418930_at) |
| 2.023 | |
| Chemokine (C-X-C motif) ligand 11 (1419697_at) |
| 1.205 | |
| Chemokine (C-X-C motif) ligand 13 (1448859_at) |
| 0.360 | |
| Chemokine (C-X-C motif) ligand 9 (1418652_at) |
| 0.698 | |
| DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (1436562_at) |
| 0.520 | |
| Guanylate binding protein 1 (1420549_at) |
| 1.349 | |
| Guanylate binding protein 2 (1435906_x_at) |
| 1.602 | |
| Guanylate binding protein 3 (1418392_a_at) |
| 0.919 | |
| Guanylate binding protein 6 (1438676_at) |
| 1.507 | |
| Guanylate binding protein 7 (1434380_at) |
| 0.459 | |
| Histocompatibility 28 (1421596_s_at) |
| 0.777 | |
| Histocompatibility 2, T region locus 24 (1422160_at) |
| 0.847 | |
| Intercellular adhesion molecule 1 (1424067_at) |
| 0.490 | |
| Interferon induced with helicase C domain 1 (1426276_at) |
| 0.664 | |
| Immunoglobulin heavy constant mu (1427351_s_at) |
| −0.729 | |
| Interleukin 1 receptor antagonist (1425663_at) |
| 0.872 | |
| Immunity-related GTPase family M member 1 (1418825_at) |
| 0.793 | |
| Kelch-like 6 (Drosophila) (1437886_at) |
| −0.637 | |
| Mucosa associated lymphoid tissue lymphoma translocation gene 1 (1456126_at) |
| 0.578 | |
| Major facilitator superfamily domain containing 6 (1424463_at) |
| −0.602 | |
| Macrophage migration inhibitory factor (1416335_at) |
| 0.731 | |
| Myeloid/lymphoid or mixed-lineage leukemia 5 (1434704_at) |
| −0.401 | |
| Myxovirus (influenza virus) resistance 1 (1451905_a_at) |
| 1.226 | |
| Myxovirus (influenza virus) resistance 2 (1419676_at) |
| 0.494 | |
| NA (1416016_at) | NA | 0.347 | |
| NA (1417314_at) | NA | 0.573 | |
| NA (1424775_at) | NA | 0.540 | |
| NA (1439343_at) | NA | −0.416 | |
| NA (1447927_at) | NA | 1.137 | |
| NA (1449009_at) | NA | 1.397 | |
| Neutrophil cytosolic factor 1 (1425609_at) |
| −0.491 | |
| 2′-5′ oligoadenylate synthetase 3 (1425374_at) |
| 0.545 | |
| 2′-5′ oligoadenylate synthetase-like 2 (1453196_a_at) |
| 0.762 | |
| ORAI calcium release-activated calcium modulator 1 (1424990_at) |
| −0.362 | |
| Proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) (1422962_a_at) |
| 0.424 | |
| RAB27A, member RAS oncogene family (1429123_at) |
| −0.393 | |
| Radical S-adenosyl methionine domain containing 2 (1421009_at) |
| 2.096 | |
| Serine (or cysteine) peptidase inhibitor, clade A, member 3G (1424923_at) |
| 0.778 | |
| Tumor necrosis factor (1419607_at) |
| 0.784 | |
| Tumor necrosis factor (ligand) superfamily, member 10 (1459913_at) |
| 0.495 | |
| Tumor necrosis factor (ligand) superfamily, member 9 (1422924_at) |
| 0.726 | |
| Chemokine signaling pathway (KEGG entry: mmu04062) | |||
| Adrenergic receptor kinase, beta 1 (1451992_at) |
| −0.420 | |
| Arrestin, beta 2 (1451987_at) |
| −0.443 | |
| Chemokine (C-C motif) ligand 12 (1419282_at) |
| 0.515 | |
| Chemokine (C-C motif) ligand 2 (1420380_at) |
| 0.738 | |
| Chemokine (C-C motif) ligand 24 (1450488_at) |
| −0.485 | |
| Chemokine (C-C motif) ligand 3 (1419561_at) |
| 0.643 | |
| Chemokine (C-C motif) ligand 4 (1421578_at) |
| 0.710 | |
| Chemokine (C-C motif) ligand 5 (1418126_at) |
| 2.250 | |
| Chemokine (C-C motif) ligand 7 (1421228_at) |
| 0.523 | |
| Chemokine (C-C motif) receptor 1 (1419609_at) |
| 0.481 | |
| C-src tyrosine kinase (1423518_at) |
| −0.387 | |
| Chemokine (C-X3-C) receptor 1 (1450020_at) |
| −0.379 | |
| Chemokine (C-X-C motif) ligand 1 (1419209_at) |
| 0.808 | |
| Chemokine (C-X-C motif) ligand 10 (1418930_at) |
| 2.023 | |
| Chemokine (C-X-C motif) ligand 11 (1419697_at) |
| 1.205 | |
| Chemokine (C-X-C motif) ligand 13 (1448859_at) |
| 0.360 | |
| Chemokine (C-X-C motif) ligand 9 (1418652_at) |
| 0.698 | |
| Gardner-Rasheed feline sarcoma viral (Fgr) oncogene homolog (1442804_at) |
| 0.472 | |
| Neutrophil cytosolic factor 1 (1425609_at) |
| −0.491 | |
| Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha (1448306_at) |
| 0.500 | |
| Protein kinase, cAMP dependent, catalytic, beta (1420611_at) |
| −0.434 | |
| Signal transducer and activator of transcription 1 (1450034_at) |
| 0.784 | |
| Signal transducer and activator of transcription 2 (1421911_at) |
| 0.413 | |
| Signal transducer and activator of transcription 3 (1426587_a_at) |
| −0.371 | |
Fig. 8BNIP3 and CTSE transcriptomic and western blot analyses with RNAs and protein extracts from L. m.-infected and HBSS-starved BMDM as well as determination of the infection rates of L. m.-infected BMDM after BNIP3 and CTSE downregulation by RNA interference. Methods: (a, b) BMDM from BALB/c mice were infected with L. m. promastigotes for 1 h or 24 h. Uninfected control BMDM were incubated for the same amount of time in RPMI medium or starved for 1 h in HBSS. The Proteins were harvested and subjected to western blot analysis with specific antibodies against BNIP3 and CTSE. Western blots from 3 independent experiments were analyzed densitometrically. ACTB served as the internal loading control. Total RNA was harvested from L. m.-infected BMDM and uninfected control BMDM. Affymetrix® chips were hybridized with RNA samples from 2 independent experiments and analyzed densitometrically. c Additionally, L. m.-infected BMDM were transfected with specific siRNAs 20 h p.i. to downregulate the expression of BNIP3 and CTSE. L. m.-infected control BMDM were transfected with negative control siRNA. Infection rates were determined 48 h p.i. in 2 independent experiments. Results: (a) BNIP3 and CTSE were significantly overexpressed in L. m.-infected BMDM 24 h p.i. compared to uninfected control BMDM. b Densitometric analyses of western blot experiments confirmed this overexpression 24 h p.i. and showed that CTSE was also overexpressed in L. m.-infected BMDM 1 h p.i.. At the mRNA level, Bnip3 was overexpressed in L. m.-infected BMDM 1 and 24 h p.i. and Ctse was downregulated in L. m.-infected BMDM 24 h p.i.. c A significant increase in the infection rates was detected in L. m.-infected BMDM after downregulation of protein expression of BNIP3 or CTSE compared to L. m.-infected BMDM transfected with negative control siRNA. L. m.-inf. = L. m.-infected, neg. control = negative control, n.s. = not significant, RFU = relative fluorescence units, * p ≤ 0.05, ** p ≤ 0.01,*** p ≤ 0.001
Fig. 10Global analysis of differentially expressed miRNAs in L. m.-infected BMDM, bioinformatical prediction of miRNA interactions with LISA, and infection rates of L. m.-infected BMDM after transfection with mmu-miR-101c or mmu-miR-129-5p mimics as well as mmu-miR-155-5p or mmu-miR-210-5p inhibitors. Methods: (a, b, d) BMDM from BALB/c mice were infected with L. m. promastigotes for 24 h. Uninfected control BMDM were incubated for the same amount of time in RPMI medium. Total RNA was harvested from L. m.-infected BMDM and uninfected control BMDM. Affymetrix® chips were hybridized with RNA samples from 2 independent experiments and analyzed densitometrically. Putative interactions between differentially expressed miRNAs and LISA members were predicted bioinformatically and represented in MONA-of-LISA. c Additionally, L. m.-infected BMDM were transfected with miRNA mimics or inhibitors 20 h p.i.. L. m.-infected control BMDM were transfected with a negative control of miRNA mimics or inhibitors. The infection rates were determined 48 h p.i. in 2 independent experiments. Results: (a, b) Differentially expressed miRNAs were detected in L. m.-infected BMDM 24 h p.i.. The results were presented in MA plots. Large dots represent probe sets, which were significantly and differentially expressed (FDR < 0.05). Dot and table colors correspond to the direction of miRNA expression changes (red = significant upregulation; blue = significant downregulation). b Table shows the significantly regulated miRNAs at 24 h p.i.. Accession No. provides detailed information about respective miRNA in (http://www.mirbase.org/). c A significant decrease in the infection rates was detected in L. m.-infected BMDM after transfection with mmu-miR-101c, mmu-miR-129-5p, and mmu-miR-210-5p compared to L. m.-infected BMDM transfected with a negative control of miRNA mimics or inhibitors. Transfection with mmu-miR-155-5p did not change the infection rate. d Putative interactions of differentially expressed miRNAs with LISA were identified and presented in MONA-of-LISA. Dotted gray lines show connections between the miRNA and the mRNAs of LISA. Solid gray lines are the connections between mRNAs already known from LISA. Node colors correspond to the direction of the gene product expression changes (red nodes = significant upregulation; blue nodes = significant downregulation). Accession No. = Accession number, Affymetrix ID = Affymetrix identifier, inhib. = inhibitor, logFC = log(fold change), neg. control = negative control, n.s. = not significant, p.i. = post infection,* = genes of glycolysis,** p ≤ 0.01, *** p ≤ 0.001
Fig. 11Schematic summary of results. a 0 h p.i.: macrophages were infected with L. m. promastigotes. b 10 min p.i.: promastigotes attached to macrophages and were phagocytosed by the cells. c 1 h p.i. (early infection phase): promastigotes differentiated intracellularly into amastigotes. At this point, the differentiation was not complete. Hyperphosphorylation of MTOR and RPS6 suggested autophagy inhibition. d 24 h p.i. (late infection phase): amastigote differentiation was completed. ATG5, BNIP3, CTSE, MIF, UB, and miRNAs mmu-miR-155-5p and mmu-miR-210-5p, were overexpressed. Expression of miRNAs mmu-miR-101c and mmu-miR-129-5p was downregulated. The LC3B-II/LC3B-I ratio was elevated and suggested an increased autophagic flux. Glycolytic genes were upregulated. Overexpressed MIF might have attracted new uninfected host macrophages. Putative regulatory mechanisms at the RNA level were identified, which were summarized in LISA and MONA-of-LISA. Additionally, inflammatory functions (e.g., the immune response and chemokine signaling pathway) were upregulated, which indicates L. m.-infected BMDM had an inflammatory phenotype. e 48 h p.i.: amastigotes were autophagically digested, which resulted in a decline in the infection rate. p.i. = post infection